{"id":94369,"date":"2026-04-03T16:46:26","date_gmt":"2026-04-03T16:46:26","guid":{"rendered":"https:\/\/mybusinessfuture.com\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/"},"modified":"2026-04-14T11:39:12","modified_gmt":"2026-04-14T11:39:12","slug":"1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a","status":"publish","type":"post","link":"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/","title":{"rendered":"1,451 AI Medical Devices Approved in the U.S."},"content":{"rendered":"<p style=\"background:#F21F05;color:#fff;padding:4px 14px;border-radius:20px;font-size:0.85em;margin-bottom:18px\">5 min Read Time<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px\"><strong>The U.S. Food and Drug Administration (FDA) has approved exactly 1,451 AI-powered medical devices through the end of 2025 &#8211; 295 of them alone in the past year. In Europe, there isn\u2019t even a comparable public database. While U.S. hospitals routinely deploy AI diagnostics, German hospitals rely on isolated, bespoke solutions &#8211; and wait for the AI Act, whose high-risk requirements won\u2019t take effect until 2027. A status report.<\/strong><\/p>\n<div style=\"border-left:4px solid #F21F05;padding:16px 20px;margin:24px 0;background:#fff5f5;border-radius:0 8px 8px 0\">\n<h2 style=\"margin-top:0;margin-bottom:12px\">The Key Takeaways<\/h2>\n<ul>\n<li><strong>1,451 AI medical devices approved in the U.S.<\/strong>: 295 in 2025 alone; 76% are for radiology. GE HealthCare leads with 120 approvals (The Imaging Wire, March 2026).<\/li>\n<li><strong>Europe lacks oversight<\/strong>: No public database exists for CE-marked AI medical devices. At least 219 are estimated to be on the market (as of January 2025).<\/li>\n<li><strong>Only 2.4% are randomized<\/strong>: Of 903 FDA-approved AI devices reviewed, 24.1% had <em>no<\/em> clinical study at all. Just 2.4% underwent randomized controlled trials; 8.1% were tested prospectively (JAMA Network Open, 2025).<\/li>\n<li><strong>DACH hospitals <em>are<\/em> deploying AI<\/strong>: Asklepios uses Aidoc across 25+ hospitals; the Vara-PRAIM study boosted breast cancer detection by 17.6% among 463,094 women.<\/li>\n<li><strong>AI Act high-risk deadline: August 2027.<\/strong> Until then, medical AI systems must meet full requirements for risk management, data quality, and human oversight.<\/li>\n<\/ul>\n<\/div>\n<h2>What is Ai-powered?<\/h2>\n<p>Ai-powered is a concrete priority for companies in 2026 because it directly shapes digital care processes, privacy requirements and hospital IT. This article uses synaforce as an example to show which requirements, figures and operational steps matter in practice.<\/p>\n<h2 style=\"padding-top:64px;margin-bottom:20px\">295 approvals in one year: What the FDA numbers reveal<\/h2>\n<p style=\"line-height:1.8;margin-bottom:20px\">Since 2017, the FDA has maintained a publicly accessible database of all AI-powered medical devices granted market authorization. The figures show an unmistakable trend: from 29 approvals in 2017 to 295 in 2025 &#8211; a record that decisively surpassed the previous year\u2019s high of 223.<\/p>\n<div class=\"evm-stat evm-stat-highlight\" style=\"text-align:center;background:#fff5f5;border-radius:12px;padding:32px 24px;margin:32px 0\">\n<div style=\"font-size:clamp(1.5em,5vw,2.4em);font-weight:700;color:#c0392b;letter-spacing:-0.03em\">1.451<\/div>\n<div style=\"font-size:15px;color:#444;margin-top:8px\">AI medical devices with FDA approval (cumulative through end of 2025)<\/div>\n<div style=\"font-size:12px;color:#888;margin-top:8px\">Source: The Imaging Wire \/ FDA, March 2026<\/div>\n<\/div>\n<p style=\"line-height:1.8;margin-bottom:20px\">76% of all approved AI devices serve radiology &#8211; a domain where pattern recognition on large image datasets excels. GE HealthCare tops the rankings with 120 approvals, followed by Siemens Healthineers with 89. That two of the top three manufacturers have European roots only underscores the regulatory asymmetry between the U.S. and the EU.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px\">Yet not every approval signals clinical value. An analysis published in <em>JAMA Network Open<\/em> (April 2025) examined 903 FDA-cleared AI medical devices &#8211; and delivered a sobering verdict: 24.1% lacked <em>any<\/em> clinical validation study. Only 2.4% had undergone randomized controlled testing; 8.1% were evaluated prospectively. Roughly 90% of these devices relied solely on retrospective data &#8211; or no clinical evidence whatsoever.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px\">That means the FDA\u2019s tally of 1,451 approvals is impressive as a barometer of market momentum &#8211; but only a limited indicator of quality. For hospital procurement teams evaluating an AI system, FDA clearance alone is insufficient. What matters are prospective studies conducted on comparable patient populations &#8211; and transparent, reproducible clinical validation within <em>their own<\/em> care environment.<\/p>\n<h2 style=\"padding-top:64px;margin-bottom:20px\">Europe\u2019s blind spot: No database, no transparency<\/h2>\n<p style=\"line-height:1.8;margin-bottom:20px\">In Europe, no equivalent public list exists. Neither the European Medicines Agency (EMA) nor Germany\u2019s Federal Institute for Drugs and Medical Devices (BfArM) maintains an accessible database of certified AI medical devices. The EU\u2019s intended transparency tool &#8211; EUDAMED &#8211; has been under development for years. Individual modules will become mandatory starting in May 2026, but a complete overview of all AI products on the European market won\u2019t be available for several more years.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px\">Independent trackers estimate at least 219 CE-marked AI medical devices are already on the market (as of January 2025). The true number is likely higher &#8211; but nobody knows for sure. For hospital buyers weighing which AI system to evaluate, that\u2019s a real operational problem.<\/p>\n<div style=\"margin:32px 0\">\n<table style=\"width:100%;border-collapse:collapse;font-size:0.95em\">\n<thead>\n<tr style=\"background:#F21F05;color:#fff\">\n<th style=\"padding:12px 16px;text-align:left\">Criterion<\/th>\n<th style=\"padding:12px 16px;text-align:center\">USA (FDA)<\/th>\n<th style=\"padding:12px 16px;text-align:center\">Europe (CE\/MDR)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #e9ecef\">\n<td style=\"padding:10px 16px;font-weight:600\">Public AI database<\/td>\n<td style=\"padding:10px 16px;text-align:center\">Yes, since 2017<\/td>\n<td style=\"padding:10px 16px;text-align:center\">No (EUDAMED under construction)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #e9ecef;background:#fafafa\">\n<td style=\"padding:10px 16px;font-weight:600\">Approved AI products<\/td>\n<td style=\"padding:10px 16px;text-align:center\">1.451 (cumulative)<\/td>\n<td style=\"padding:10px 16px;text-align:center\">At least 219 (estimated)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #e9ecef\">\n<td style=\"padding:10px 16px;font-weight:600\">Approval pace in 2025<\/td>\n<td style=\"padding:10px 16px;text-align:center\">295 new devices<\/td>\n<td style=\"padding:10px 16px;text-align:center\">Unknown (no official statistics)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #e9ecef;background:#fafafa\">\n<td style=\"padding:10px 16px;font-weight:600\">AI-specific regulation<\/td>\n<td style=\"padding:10px 16px;text-align:center\">FDA framework since 2021<\/td>\n<td style=\"padding:10px 16px;text-align:center\">AI Act effective August 2027<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #e9ecef\">\n<td style=\"padding:10px 16px;font-weight:600\">Clinical validation<\/td>\n<td style=\"padding:10px 16px;text-align:center\">Required &#8211; but inconsistently enforced<\/td>\n<td style=\"padding:10px 16px;text-align:center\">MDR-compliant (stricter)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2 style=\"padding-top:64px;margin-bottom:20px\">DACH hospitals deploy AI &#8211; but in siloed solutions<\/h2>\n<p style=\"line-height:1.8;margin-bottom:20px\">Despite regulatory gaps at the European level, individual DACH hospitals are already using AI diagnostics in routine clinical practice. Results are promising &#8211; but remain fragmented.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px\">Asklepios, one of Germany\u2019s largest private hospital operators, has installed the Israeli AI system Aidoc in over 25 hospitals. The software analyzes CT scans in real time, flagging strokes, intracranial hemorrhages, and vertebral fractures &#8211; funded via KHZG innovation grants. Its key advantage? Aidoc reprioritizes radiologists\u2019 worklists so time-critical cases appear at the top &#8211; not buried in the queue.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px\">The largest prospective study on AI use in diagnostics also originates in Germany. Published in <em>Nature Medicine<\/em>, the Vara-PRAIM study analyzed over 463,000 mammography screenings &#8211; and found a 17.6% increase in breast cancer detection, alongside reduced workload for radiologists. It remains the world\u2019s largest prospective trial of its kind.<\/p>\n<blockquote style=\"border-left:4px solid #F21F05;margin:32px 0;padding:20px 24px;background:#fafafa;border-radius:0 8px 8px 0;font-size:1.1em;line-height:1.6;color:#333\"><p>\n&#8220;The question is no longer whether AI works in diagnostics. The question is how we bridge the gap from research into routine clinical practice &#8211; regulatorily, organizationally, and economically.&#8221;<br \/>\n<cite style=\"margin-top:12px;font-size:0.8em;color:#888;font-style:normal\">&#8211; Prof. Alexander Berens, University of T\u00fcbingen (press release, 2025)<\/cite>\n<\/p><\/blockquote>\n<p style=\"line-height:1.8;margin-bottom:20px\">The problem? Each implementation is a standalone project. There is no national standard for integrating AI into hospital information systems, no unified interface, and no central registry tracking which clinic uses which system. Although Germany\u2019s Innovation Fund (G-BA) supports the xR.AI project to promote standardized AI use in radiology, nationwide rollout remains distant.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px\">The consequence? German hospitals seeking to introduce AI diagnostics must navigate every step themselves &#8211; from product selection and integration into their hospital information system (KIS), to training radiologists. Added complications include unresolved liability questions, neither settled nationally nor at the EU level. If an AI system misses a finding &#8211; and the treating physician relies on it &#8211; who bears responsibility? The Medical Device Regulation (MDR) governs manufacturer product liability, but physicians\u2019 duty of care remains unchanged. In practice, this legal ambiguity leads many radiologists to treat AI findings not as decision-making inputs, but merely as supplementary hints.<\/p>\n<h2 style=\"padding-top:64px;margin-bottom:20px\">AI Act takes effect in 2027: What lies ahead for MedTech companies<\/h2>\n<p style=\"line-height:1.8;margin-bottom:20px\">The EU AI Act entered into force in August 2024 &#8211; but medical devices benefit from a transition period: full high-risk requirements apply only from 2 August 2027 onward. AI systems classified as medical devices under the MDR or IVDR are automatically designated as high-risk AI.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px\">What does that mean in practice? Manufacturers must implement AI-specific risk management systems, meet stringent data quality and data governance standards, produce technical documentation exceeding MDR requirements, and embed mechanisms for human oversight. The burden is substantial &#8211; especially for smaller firms.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px\">A silver lining: In November 2025, the European Commission proposed an omnibus simplification package aimed at reducing overlap between the AI Act and the MDR\/IVDR. Instead of duplicate documentation and dual conformity assessments, a single integrated process is envisioned. Adoption is expected by summer 2026.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px\">For German MedTech SMEs &#8211; 93% of the sector employs fewer than 250 people &#8211; this isn\u2019t academic. Over recent years, the MDR has already driven some manufacturers to withdraw products from the European market because certification costs outweighed revenue. If the AI Act layers similar bureaucracy on top, consolidation will accelerate.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px\">At the same time, regulation creates a quality advantage: AI medical devices compliant with <em>both<\/em> the MDR and the AI Act gain a trust premium over FDA-only cleared devices. European manufacturers who clear both hurdles can leverage that dual compliance as a differentiator in global markets &#8211; <em>provided<\/em> they survive the transition phase financially and operationally through 2027.<\/p>\n<h2 style=\"padding-top:64px;margin-bottom:20px\">Accelerate &#8211; or fall behind<\/h2>\n<p style=\"line-height:1.8;margin-bottom:20px\">The global AI-in-healthcare market stood at an estimated $21.66 billion in 2025. By 2030, it\u2019s projected to exceed $110 billion &#8211; a compound annual growth rate (CAGR) of 38.6% (MarketsandMarkets). PwC Strategy&amp; estimates Europe\u2019s potential at $203 billion by 2030.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px\">Germany hosts strong AI players in MedTech &#8211; including Siemens Healthineers, Brainomix, Vara, and Merantix. Clinical research operates at international standards &#8211; the PRAIM study proves that emphatically. What\u2019s missing is the bridge from research to routine care: a European AI database delivering transparency; a harmonized approval process that doesn\u2019t overwhelm SMEs; and a hospital landscape that treats AI not as a grant-funded pilot, but as a standard clinical tool.<\/p>\n<p style=\"line-height:1.8;margin-bottom:20px\">In eight years, the FDA has approved 1,451 AI medical devices &#8211; and learned to adapt its processes along the way. Europe, in the same timeframe, drafted a regulation whose impact won\u2019t begin until 2027. Anyone who fails to see that lag as a strategic risk hasn\u2019t grasped the market\u2019s velocity.<\/p>\n<h2 style=\"margin-top:40px;margin-bottom:8px\">Frequently Asked Questions<\/h2>\n<details style=\"border:1px solid #e9ecef;border-radius:6px;background:#f8f9fa;margin-bottom:8px\">\n<summary style=\"padding:14px 18px;cursor:pointer;font-weight:600\"><strong>How many AI medical devices has the FDA approved through 2025?<\/strong><\/summary>\n<p style=\"padding:14px 20px 18px;color:#495057;line-height:1.7\">Through the end of 2025, the FDA has approved a total of 1,451 AI-powered medical devices. Of those, 295 were approved in 2025 alone &#8211; a record. 76% serve radiology; GE HealthCare leads the rankings with 120 approvals.<\/p>\n<\/details>\n<details style=\"border:1px solid #e9ecef;border-radius:6px;background:#f8f9fa;margin-bottom:8px\">\n<summary style=\"padding:14px 18px;cursor:pointer;font-weight:600\"><strong>Does Europe maintain a database for AI medical devices?<\/strong><\/summary>\n<p style=\"padding:14px 20px 18px;color:#495057;line-height:1.7\">No. Unlike the FDA, neither the EMA nor the BfArM publishes a public list of CE-marked AI medical devices. The EU\u2019s EUDAMED database is still under development; individual modules become mandatory starting in May 2026. A comprehensive overview won\u2019t be available for years.<\/p>\n<\/details>\n<details style=\"border:1px solid #e9ecef;border-radius:6px;background:#f8f9fa;margin-bottom:8px\">\n<summary style=\"padding:14px 18px;cursor:pointer;font-weight:600\"><strong>When do the AI Act\u2019s requirements take effect for medical devices?<\/strong><\/summary>\n<p style=\"padding:14px 20px 18px;color:#495057;line-height:1.7\">Full high-risk requirements of the EU AI Act for medical AI systems apply from 2 August 2027. AI systems falling under the MDR or IVDR are automatically classified as high-risk and must comply with AI-specific risk management, data quality, and human oversight requirements.<\/p>\n<\/details>\n<details style=\"border:1px solid #e9ecef;border-radius:6px;background:#f8f9fa;margin-bottom:8px\">\n<summary style=\"padding:14px 18px;cursor:pointer;font-weight:600\"><strong>Which German hospitals already deploy AI diagnostics?<\/strong><\/summary>\n<p style=\"padding:14px 20px 18px;color:#495057;line-height:1.7\">Asklepios deploys the AI system Aidoc for CT analysis across more than 25 hospitals (funded via KHZG grants). The Vara-PRAIM study at German breast cancer centers increased detection rates by 17.6% among 463,094 screened women. The G-BA\u2019s xR.AI project promotes standardized AI use in radiology.<\/p>\n<\/details>\n<details style=\"border:1px solid #e9ecef;border-radius:6px;background:#f8f9fa;margin-bottom:8px\">\n<summary style=\"padding:14px 18px;cursor:pointer;font-weight:600\"><strong>How large is the AI-in-healthcare market?<\/strong><\/summary>\n<p style=\"padding:14px 20px 18px;color:#495057;line-height:1.7\">The global market stood at $21.66 billion in 2025 and is projected to surpass $110 billion by 2030 (CAGR 38.6%, MarketsandMarkets). PwC Strategy&amp; estimates Europe\u2019s potential at $203 billion by 2030.<\/p>\n<\/details>\n<div class=\"evm-styled-box\" style=\"background:#fff5f5;border-radius:8px;padding:20px 24px;margin:24px 0;border-top:3px solid #F21F05\">\n<h2 style=\"margin-top:0;margin-bottom:12px;font-size:1.05em\">Editor\u2019s reading recommendations<\/h2>\n<ul>\n<li><a href=\"https:\/\/mybusinessfuture.com\/en\/?p=84954\">More than half of Germans would welcome a second opinion from \u201cDr. AI\u201d<\/a><\/li>\n<li><a href=\"https:\/\/mybusinessfuture.com\/epa-in-hospitals-only-40-are-piloting-penalties-loom-from-april\/\">ePA in hospitals: Only 40% are piloting &#8211; and sanctions loom from April<\/a><\/li>\n<li><a href=\"https:\/\/mybusinessfuture.com\/?p=84659\">From legacy systems to connected care: How synaforce transforms hospitals<\/a><\/li>\n<\/ul>\n<\/div>\n<p style=\"text-align:right;font-style:italic;color:#888;font-size:0.85em\">Header Image Source: Pexels \/ MART PRODUCTION (px:7089623)<\/p>\n<div class=\"evm-synaforce-cluster-links\" data-evm-synaforce-cluster=\"1\">\n<h2>More on this synaforce topic<\/h2>\n<p>Additional service details, use cases and background are available from <a href=\"https:\/\/www.synaforce.com\/?utm_source=mbf-media&amp;utm_medium=fachartikel&amp;utm_campaign=synaforce-2026\" rel=\"noopener\" target=\"_blank\">synaforce for healthcare IT and security operations<\/a>.<\/p>\n<ul>\n<li><a href=\"https:\/\/mybusinessfuture.com\/en\/hospital-epa-sanctions-april\/\">ePA Sanctions for Hospitals Start in April \u2013 Are You Ready?<\/a><\/li>\n<li><a href=\"https:\/\/mybusinessfuture.com\/en\/fusion-synaforce-unites-strong-it-partners-from-germany\/\">synaforce Unites Top German IT Partners via Buy-and-Build<\/a><\/li>\n<li><a href=\"https:\/\/mybusinessfuture.com\/en\/positive-life-cycle-assessment-synaforce-high-end-datacenter\/\">Positive Life Cycle Assessment at synaforce&#x27;s Data Center<\/a><\/li>\n<\/ul>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>5 min Read Time The U.S. Food and Drug Administration (FDA) has approved exactly 1,451 AI-powered medical devices through the end of 2025 &#8211; 295 of them alone in the past year. In Europe, there isn\u2019t even a comparable public database. While U.S. hospitals routinely deploy AI diagnostics, German hospitals rely on isolated, bespoke solutions [&hellip;]<\/p>\n","protected":false},"author":205,"featured_media":97362,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_yoast_wpseo_focuskw":"ai-powered","_yoast_wpseo_title":"1,451 AI Medical Devices Approved in the U.S.","_yoast_wpseo_metadesc":"The U.S. has approved 1,451 AI medical devices. Europe doesn't even maintain a central list. See how regulatory gaps shape global health tech.","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","_yoast_wpseo_meta-robots-adv":"","_yoast_wpseo_canonical":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":0,"_yoast_wpseo_twitter-title":"","_yoast_wpseo_twitter-description":"","_yoast_wpseo_twitter-image":"","_yoast_wpseo_twitter-image-id":0,"featured_post_sortierung":0,"featured_post":0,"pre_headline":"","bildquelle":"","teasertext":"","language":"de","footnotes":""},"categories":[1146,1278],"tags":[],"class_list":{"0":"post-94369","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","6":"hentry","7":"category-life-sciences-health-care","9":"entry"},"wpml_language":"en","wpml_translation_of":92737,"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>1,451 AI Medical Devices Approved in the U.S.<\/title>\n<meta name=\"description\" content=\"The U.S. has approved 1,451 AI medical devices. Europe doesn&#039;t even maintain a central list. See how regulatory gaps shape global health tech.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"1,451 AI Medical Devices Approved in the U.S.\" \/>\n<meta property=\"og:description\" content=\"The U.S. has approved 1,451 AI medical devices. Europe doesn&#039;t even maintain a central list. See how regulatory gaps shape global health tech.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/\" \/>\n<meta property=\"og:site_name\" content=\"MyBusinessFuture\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MyBusinessFuture\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-03T16:46:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-14T11:39:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/03\/ki-diagnostik-medizin-fda-2026.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tobias Massow\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@mbusinessfuture\" \/>\n<meta name=\"twitter:site\" content=\"@mbusinessfuture\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tobias Massow\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/\"},\"author\":{\"name\":\"Tobias Massow\",\"@id\":\"https:\/\/mybusinessfuture.com\/#\/schema\/person\/5a5f67d388de091844cc887ac56f3760\"},\"headline\":\"1,451 AI Medical Devices Approved in the U.S.\",\"datePublished\":\"2026-04-03T16:46:26+00:00\",\"dateModified\":\"2026-04-14T11:39:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/\"},\"wordCount\":1724,\"publisher\":{\"@id\":\"https:\/\/mybusinessfuture.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/04\/ki-diagnostik-medizin-fda-2026-en.jpg\",\"articleSection\":[\"Life Sciences &amp; Health Care\",\"Life Sciences &amp; Health Care\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/\",\"url\":\"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/\",\"name\":\"1,451 AI Medical Devices Approved in the U.S.\",\"isPartOf\":{\"@id\":\"https:\/\/mybusinessfuture.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/04\/ki-diagnostik-medizin-fda-2026-en.jpg\",\"datePublished\":\"2026-04-03T16:46:26+00:00\",\"dateModified\":\"2026-04-14T11:39:12+00:00\",\"description\":\"The U.S. has approved 1,451 AI medical devices. Europe doesn't even maintain a central list. See how regulatory gaps shape global health tech.\",\"breadcrumb\":{\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/#primaryimage\",\"url\":\"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/04\/ki-diagnostik-medizin-fda-2026-en.jpg\",\"contentUrl\":\"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/04\/ki-diagnostik-medizin-fda-2026-en.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Digitally connected hospital workstation with medical monitors \u2013 article about ai-powered and synaforce\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/mybusinessfuture.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"1,451 AI Medical Devices Approved in the U.S.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mybusinessfuture.com\/#website\",\"url\":\"https:\/\/mybusinessfuture.com\/\",\"name\":\"MyBusinessFuture\",\"description\":\"B2B-Magazin f\u00fcr Digitalisierung, KI und Business-Innovation \u2014 Fachartikel f\u00fcr IT-Entscheider im DACH-Raum\",\"publisher\":{\"@id\":\"https:\/\/mybusinessfuture.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mybusinessfuture.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mybusinessfuture.com\/#organization\",\"name\":\"MyBusinessFuture\",\"url\":\"https:\/\/mybusinessfuture.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mybusinessfuture.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2020\/10\/MBF-logo-schwarz.png\",\"contentUrl\":\"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2020\/10\/MBF-logo-schwarz.png\",\"width\":398,\"height\":241,\"caption\":\"MyBusinessFuture\"},\"image\":{\"@id\":\"https:\/\/mybusinessfuture.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/MyBusinessFuture\",\"https:\/\/x.com\/mbusinessfuture\",\"https:\/\/www.linkedin.com\/showcase\/mybusinessfuture\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mybusinessfuture.com\/#\/schema\/person\/5a5f67d388de091844cc887ac56f3760\",\"name\":\"Tobias Massow\",\"description\":\"Tobias Massow ist Gesch\u00e4ftsf\u00fchrer der Evernine Media GmbH und Herausgeber von MyBusinessFuture. Er verantwortet die strategische Ausrichtung des Magazins und des gesamten MBF Media Netzwerks mit vier B2B-Fachmagazinen f\u00fcr IT-Entscheider im deutschsprachigen Raum.\",\"sameAs\":[\"https:\/\/www.linkedin.com\/in\/tobias-massow\/\"],\"url\":\"https:\/\/mybusinessfuture.com\/en\/experte\/tobias-evm\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"1,451 AI Medical Devices Approved in the U.S.","description":"The U.S. has approved 1,451 AI medical devices. Europe doesn't even maintain a central list. See how regulatory gaps shape global health tech.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/","og_locale":"en_US","og_type":"article","og_title":"1,451 AI Medical Devices Approved in the U.S.","og_description":"The U.S. has approved 1,451 AI medical devices. Europe doesn't even maintain a central list. See how regulatory gaps shape global health tech.","og_url":"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/","og_site_name":"MyBusinessFuture","article_publisher":"https:\/\/www.facebook.com\/MyBusinessFuture","article_published_time":"2026-04-03T16:46:26+00:00","article_modified_time":"2026-04-14T11:39:12+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/03\/ki-diagnostik-medizin-fda-2026.jpg","type":"image\/jpeg"}],"author":"Tobias Massow","twitter_card":"summary_large_image","twitter_creator":"@mbusinessfuture","twitter_site":"@mbusinessfuture","twitter_misc":{"Written by":"Tobias Massow","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/#article","isPartOf":{"@id":"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/"},"author":{"name":"Tobias Massow","@id":"https:\/\/mybusinessfuture.com\/#\/schema\/person\/5a5f67d388de091844cc887ac56f3760"},"headline":"1,451 AI Medical Devices Approved in the U.S.","datePublished":"2026-04-03T16:46:26+00:00","dateModified":"2026-04-14T11:39:12+00:00","mainEntityOfPage":{"@id":"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/"},"wordCount":1724,"publisher":{"@id":"https:\/\/mybusinessfuture.com\/#organization"},"image":{"@id":"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/#primaryimage"},"thumbnailUrl":"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/04\/ki-diagnostik-medizin-fda-2026-en.jpg","articleSection":["Life Sciences &amp; Health Care","Life Sciences &amp; Health Care"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/","url":"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/","name":"1,451 AI Medical Devices Approved in the U.S.","isPartOf":{"@id":"https:\/\/mybusinessfuture.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/#primaryimage"},"image":{"@id":"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/#primaryimage"},"thumbnailUrl":"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/04\/ki-diagnostik-medizin-fda-2026-en.jpg","datePublished":"2026-04-03T16:46:26+00:00","dateModified":"2026-04-14T11:39:12+00:00","description":"The U.S. has approved 1,451 AI medical devices. Europe doesn't even maintain a central list. See how regulatory gaps shape global health tech.","breadcrumb":{"@id":"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/#primaryimage","url":"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/04\/ki-diagnostik-medizin-fda-2026-en.jpg","contentUrl":"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2026\/04\/ki-diagnostik-medizin-fda-2026-en.jpg","width":1280,"height":853,"caption":"Digitally connected hospital workstation with medical monitors \u2013 article about ai-powered and synaforce"},{"@type":"BreadcrumbList","@id":"https:\/\/mybusinessfuture.com\/en\/1451-ai-powered-medical-devices-approved-in-the-us-europe-doesnt-even-maintain-a\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/mybusinessfuture.com\/"},{"@type":"ListItem","position":2,"name":"1,451 AI Medical Devices Approved in the U.S."}]},{"@type":"WebSite","@id":"https:\/\/mybusinessfuture.com\/#website","url":"https:\/\/mybusinessfuture.com\/","name":"MyBusinessFuture","description":"B2B-Magazin f\u00fcr Digitalisierung, KI und Business-Innovation \u2014 Fachartikel f\u00fcr IT-Entscheider im DACH-Raum","publisher":{"@id":"https:\/\/mybusinessfuture.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mybusinessfuture.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mybusinessfuture.com\/#organization","name":"MyBusinessFuture","url":"https:\/\/mybusinessfuture.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mybusinessfuture.com\/#\/schema\/logo\/image\/","url":"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2020\/10\/MBF-logo-schwarz.png","contentUrl":"https:\/\/mybusinessfuture.com\/wp-content\/uploads\/2020\/10\/MBF-logo-schwarz.png","width":398,"height":241,"caption":"MyBusinessFuture"},"image":{"@id":"https:\/\/mybusinessfuture.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MyBusinessFuture","https:\/\/x.com\/mbusinessfuture","https:\/\/www.linkedin.com\/showcase\/mybusinessfuture\/"]},{"@type":"Person","@id":"https:\/\/mybusinessfuture.com\/#\/schema\/person\/5a5f67d388de091844cc887ac56f3760","name":"Tobias Massow","description":"Tobias Massow ist Gesch\u00e4ftsf\u00fchrer der Evernine Media GmbH und Herausgeber von MyBusinessFuture. Er verantwortet die strategische Ausrichtung des Magazins und des gesamten MBF Media Netzwerks mit vier B2B-Fachmagazinen f\u00fcr IT-Entscheider im deutschsprachigen Raum.","sameAs":["https:\/\/www.linkedin.com\/in\/tobias-massow\/"],"url":"https:\/\/mybusinessfuture.com\/en\/experte\/tobias-evm\/"}]}},"_links":{"self":[{"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/posts\/94369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/users\/205"}],"replies":[{"embeddable":true,"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/comments?post=94369"}],"version-history":[{"count":4,"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/posts\/94369\/revisions"}],"predecessor-version":[{"id":97341,"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/posts\/94369\/revisions\/97341"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/media\/97362"}],"wp:attachment":[{"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/media?parent=94369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/categories?post=94369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mybusinessfuture.com\/en\/wp-json\/wp\/v2\/tags?post=94369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}